The Target Discovery and Validation Group consists of a team of basic and physician-scientists with common interests in elucidating the molecular underpinnings of fibrotic diseases. 

This group is uniquely capable of tackling difficult basic research questions by blending molecular, biochemical and biomedical studies with state-of-the-art cell-based and in vivo models of organ fibrosis.